» Articles » PMID: 16829268

Newer Modalities of Ultrasound Imaging and Treatment of the Prostate

Overview
Specialty Urology
Date 2006 Jul 11
PMID 16829268
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Gray-scale ultrasound is widely used for assessing BPH and for obtaining prostate biopsies. However, it has limited value for evaluating cancer in the prostate. To improve ultrasound as an imaging modality of the prostate, many new technologies, such as color and power Doppler, 3-dimensional ultrasound of the prostate, and contrast-enhanced ultrasound have been developed. In addition, treatment modalities using ultrasound for the treatment of BPH have been developed. This review presents the recent developments in ultrasound of the prostate.

Citing Articles

Clinical Significance of the Resistive Index of Prostatic Blood Flow According to Prostate Size in Benign Prostatic Hyperplasia.

Kwon S, Ryu J, Choi D, Lee K Int Neurourol J. 2016; 20(1):75-80.

PMID: 27032561 PMC: 4819154. DOI: 10.5213/inj.1630390.195.


Saturation biopsies for prostate cancer: current uses and future prospects.

Delongchamps N, Haas G Nat Rev Urol. 2009; 6(12):645-52.

PMID: 19901915 DOI: 10.1038/nrurol.2009.213.


Using biopsy to detect prostate cancer.

Shariat S, Roehrborn C Rev Urol. 2009; 10(4):262-80.

PMID: 19145270 PMC: 2615104.


[Rational imaging in locally advanced prostate cancer].

Beissert M, Lorenz R, Gerharz E Urologe A. 2008; 47(11):1405-16.

PMID: 18797837 DOI: 10.1007/s00120-008-1720-7.


[Imaging procedures to diagnose prostate cancer].

Seitz M, Scher B, Scherr M, Tilki D, Schlenker B, Gratzke C Urologe A. 2007; 46(10):W1435-46.

PMID: 17665166 DOI: 10.1007/s00120-007-1455-x.